Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

John Jolley

Gastroenterology San Rafael, CA Medical Doctor

NPI 1760590269 CMS profile 353020

750 Las Gallinas Ave Ste 106, San Rafael, CA 94903

Open in the dashboard

General payments

$6,669

350 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, John Jolley of San Rafael, CA is reported in the CMS Open Payments database as having received $6,669 across 350 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 73rd percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $384 16
2022 General $2,213 123
2021 General $2,809 138
2020 General $729 40
2019 General $534 33

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Jolley
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to John Jolley were reported at $0. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year John Jolley Gastroenterology median Middle half National median
2019 $534 $417 $126–$1,100 $163
2020 $729 $224 $74–$624 $114
2021 $2,809 $352 $106–$1,054 $132
2022 $2,213 $448 $129–$1,270 $149
2023 $384 $533 $150–$1,390 $160
2024 $0 $605 $160–$1,606 $164
2025 $0 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Salix Pharmaceuticals, a division of Bausch Health US, LLC $2,306 138 payments
  2. Janssen Biotech, Inc. $1,102 44 payments
  3. Nestle HealthCare Nutrition Inc. $926 46 payments
  4. Takeda Pharmaceuticals U.S.A., Inc. $856 47 payments
  5. AbbVie, Inc. $479 25 payments
  6. Ironwood Pharmaceuticals, Inc $279 11 payments
  7. Celgene Corporation $231 12 payments
  8. RedHill Biopharma Inc. $185 10 payments
  9. Intercept Pharmaceuticals, Inc. $165 10 payments
  10. Genzyme Corporation $52 3 payments
  11. Other $87 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $6,461 347 payments
  2. Education $208 3 payments
Products named General payments · program years 2019–2023
  1. XIFAXAN $1,766 113 payments
  2. STELARA $1,102 44 payments
  3. TRULANCE $965 51 payments
  4. ZENPEP $926 46 payments
  5. ENTYVIO $442 22 payments
  6. CREON $317 15 payments
  7. Linzess Gi $279 11 payments
  8. MOTEGRITY $256 14 payments
  9. ZEPOSIA $231 12 payments
  10. LINZESS Gastroenterology $229 11 payments
  11. Other $1,592 83 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

13

Median for Gastroenterology: 569

Drug cost

$17,622

Median for Gastroenterology: $104,976

Branded share of claims

100%

Median for Gastroenterology: 31.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Motegrity Prucalopride Succinate Brand 13 $17,622

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,294 Part D prescribers listed as Gastroenterology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 5 billing codes

Paid by Medicare

$3,027

Medicare's payments for the services billed

Medicare patients

29

Average age 79

Services billed

36

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 62%
High blood pressure 59%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

350 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record